BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
DNA fingerprint
,
Bleomycin
,
rs2230926
,
KLK3
,
cell-cell adhesion
,
Breast Cancer
,
Retina
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
il 1 d
Summary
General Info
Curated Studies
Most Correlated Studies
PBMCs treated with 1,25-dihydroxyvitamin D3 and glucocorticoids
Prostate and breast cancer cells treated with modulators of vitamin D signaling
1,25-dihydroxyvitamin D3-treated human monocyte-derived dendritic cells
Time course of 1,25(OH)2D treated RWPE1 cells
Changes in As4.1 cells treated with interleukin (IL) or hydrogen peroxide (HP)
Explore Curated Studies Results
Literature
Most Relevant Literature
Chondroprotective effects and multi-target mechanisms of Icariin in IL-1 beta-induced human SW 1353 …
Effects of estrogen on osteoprogenitor cells and cytokines/bone-regulatory factors in postmenopausal…
Anti-inflammatory effects of CBD in human microglial cell line infected with HIV-1.
Analysis of serum cytokine and protective vitamin D levels in severe cases of COVID-19.
The incidence of incision infections after lumbar fusion and the significance of dynamically monitor…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Vitamin D for Chemoprevention
Analysis of Hypovitaminosis D and Osteopenia/Osteoporosis in Spinal Disease Patients Who Underwent a…
The Efficacy and Safety of Topical Vitamin D and Supplementation In Acne Vulgaris The Study of VDR, …
GDM Patients and Serum Amyloid A and Interleukin-1 (IL-1) Receptor Antagonist
Low-dose IL-2 in Established T1D - The "PROREG" Study
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ